AI-Driven Automation in Cardiac Trial Highlights Research Grid’s Efficiency Potential

According to a recent LinkedIn post from Research Grid, the company participated in an SME Breakfast at Queen Mary University of London that brought together academia, healthcare providers and SMEs. The post frames effective clinical research partnerships as relationship-driven, highlighting collaboration with Queen Mary University of London and Barts Health NHS Trust.

The post describes a large cardiac imaging trial involving more than 600 patients in which Research Grid’s AI platform was used to automate data entry. Thousands of pages of patient records, including handwritten notes, scanned documents and structured data, were reportedly digitized and processed in seconds or minutes, with integrated quality checks and anonymization.

According to the post, the trial indicated potential savings of about $1.5 million in data entry costs and automation of over 24,000 staff hours. It also suggests that data quality could be improved by eliminating human error, while more than 600 patient records could be processed in seconds, positioning the platform as a tool for operational efficiency in clinical research.

The post emphasizes that this was not a simulation but a practical test of AI in a clinical environment using real patient data. For investors, these claims point to a value proposition focused on reducing structural inefficiencies in research operations, particularly where highly skilled staff spend significant time on repetitive administrative tasks.

As presented in the post, Research Grid is concentrating on implementation and scaling of traceable AI models from lab settings into real-world clinical workflows. If such results can be replicated and commercialized at scale, the company could enhance its competitive position in the clinical research technology segment and potentially expand revenue opportunities with academic and healthcare partners.